Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Erman Akkus, Medical Oncology Fellow at Ankara Üniversitesi Tıp Fakültesi, a post on X:

“Oncotype DX Colon Recurrence Score in stage II colon cancer at  ESMO Open.

• Real-word data, 938 patients
• Higher score ->worse clinicopathologial factors, higher treatment
• Score is prognostic
• In high score (41-100), ChT vs observation, colon cancer specific survival, p=0.035“

Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data

Authors:  B. Brenner, K. Shulman, A. Hubert, S. Man, R. Geva, I. Ben-Aharon, S. Fennig, M. Mishaeli, N. Yarom, G. Bar-Sela, R. Brenner, A. Shai, F.L. Baehner, C. Russell, L. Soussan-Gutman ,H. Voet, A. Bareket-Samish, and  N. Liebermann.

Source: Erman Akkus/X